Skip to main content
Clinical Trials/NCT01765205
NCT01765205
Completed
Not Applicable

The Efficacy of Newborn Screening for Critical Congenital Heart Disease

University of Florida1 site in 1 country20 target enrollmentMarch 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Congenital Cardiovascular Malformation
Sponsor
University of Florida
Enrollment
20
Locations
1
Primary Endpoint
To measure the oxygen saturation using pulse oximetry.
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

Previous studies have examined the usefulness of pulse oximetry or oxygen saturation to screen for left-sided cardiac lesions. These studies have shown that the occurrence of critical congenital cardiac malformations among asymptomatic newborns is high; the technique of pulse oximetry is reliable for detection of ductal dependant left-sided lesions, simple to operate(requires little time and can be done in the newborn nursery) and is cost effective; there is effective follow-up test (heart ultrasound) and available interventions have an effect on outcome for diagnosed newborns. The importance of this research project is to examine the overall helpfulness of measuring oximetry in newborn infants using somatic oximetry, as well ast to prepare for a population based study in the state of Florida.

Detailed Description

This study will evaluate up to 50 unaffected newborns and up to 10 known congenital heart disease (CHD) newborns using a new oximetry system. This system is interfaced to a laptop computer which computes the difference between central and lower extremity peripheral values, upper and lower body peripheral values, and records all data. This information may differentiate unaffected newborns and CHD newborns, and determine the effectiveness of pulse oximetry as a newborn screening for congenital cardiovascular malformations.

Registry
clinicaltrials.gov
Start Date
March 2010
End Date
January 2014
Last Updated
12 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Male or female subjects aged 12 hours -2 weeks.
  • Newborns with identified congenital heart disease or newborns without identified congenital heart disease.
  • Congenital Heart Diagnosis: Total Anomolous Pulmonary Venous Return (TAPVR); Atrio-ventricular Septal Defect ( AVSD); Coarctation of the Aorta; Critical Aortic Stenosis; other cyanotic legions including Hypoplastic Left Heart Syndrome ( HLHS)

Exclusion Criteria

  • Have any concurrent condition which, in the opinion of the investigator, would make the subject unsuitable for the study.

Outcomes

Primary Outcomes

To measure the oxygen saturation using pulse oximetry.

Time Frame: Baseline

The oxygen saturation will be measured by pulse oximetry on an infant's skin on the forehead and thigh. These two numbers will be recorded as whole numbers on the machine and will be compared to both groups of infants.

Study Sites (1)

Loading locations...

Similar Trials